Dual-action therapies are emerging as a groundbreaking approach in the fight against simultaneously HIV and cancer. These treatments attack various pathways within disease mechanisms, offering {a{ promise of improved efficacy and reduced side effects compared to traditional monotherapy approaches. By combining different therapeutic modalities, dual